Ignite Creation Date:
2025-12-24 @ 10:41 PM
Ignite Modification Date:
2025-12-31 @ 3:49 AM
Study NCT ID:
NCT01244035
Status:
COMPLETED
Last Update Posted:
2019-02-28
First Post:
2010-11-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Pharmacodynamics, and Pharmacokinetics of Different Dosing Regimens of MK-8266 in Participants With Hypertension (MK-8266-008)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-08-19
Start Date Type:
ACTUAL
Primary Completion Date:
2010-12-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-12-23
Completion Date Type:
ACTUAL
First Submit Date:
2010-11-17
First Submit QC Date:
None
Study First Post Date:
2010-11-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-03-20
Results First Submit QC Date:
None
Results First Post Date:
2019-02-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-24
Last Update Post Date:
2019-02-28
Last Update Post Date Type:
ACTUAL